Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study

CONTEXT: Up to 40% of patients with polycystic ovary syndrome (PCOS) have prediabetes; an optimal pharmacotherapy regimen for diabetes prevention in PCOS is yet to be established. OBJECTIVE: To evaluate clinical efficacy of exenatide (EX), metformin (MET), or combination (COM) for prediabetes in PCO...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Tao, Tao, Zhang, Yi, Zhu, Yu-Chen, Fu, Jia-Rong, Wang, Yu-Ying, Cai, Jie, Ma, Jing-Yu, Xu, Yu, Gao, Yi-Ning, Sun, Yun, Fan, WuQiang, Liu, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Clinical Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8244122/
https://ncbi.nlm.nih.gov/pubmed/32995892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa692
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados